News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

β3 agonist safe, effective for treatment of bladder dysfunction in children
15 Mar 2022
byStephen Padilla
ß3-adrenergic receptor agonists (ß3 agonists), such as mirabegron, demonstrate effectiveness and a satisfactory safety profile as adjunctive therapy in the management of paediatric neurogenic detrusor overactivity (NDO) or overactive bladder, results of a study have shown.
15 Mar 2022







